ReviewInternational dental journal2026
Advances in Nanozyme Engineering for Precision Oral Health Management.
Review in International dental journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A biomimetic urchin-like photothermal nanoplatform for the efficient eradication ofFrontiers in cellular and infection microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
INTRODUCTION AND
aimsDespite recent advances in dental care, traditional treatments suffer from poor targeting, limited stability, and unsatisfactory regenerative efficacy. This review aims to clarify the multi-level intervention targets of nanozymes for oral diseases, highlight their unique merits over conventional strategies, and provide a theoretical basis for developing novel precision oral therapeutic systems.
methodsHigh-quality literature was retrieved from PubMed, Web of Science, and other core databases, including in vitro, in vivo, and emerging clinical studies on the design, function, and applications of nanozymes in oral diseases.
conclusionsNanozymes demonstrate significant potential for targeted antibacterial therapy, oxidative stress regulation, and tissue repair within the complex oral microenvironment. Their integration with advanced delivery platforms enhances therapeutic precision. Future development should focus on multi-enzyme synergistic systems, improved biocompatibility, and clinical translation to realize their promise in precision oral medicine. CLINICAL SIGNIFICANCE: Nanozymes represent a paradigm shift from passive to active, dynamic oral therapeutics. They offer a promising strategy for managing biofilm-associated diseases (caries, periodontitis) and complex conditions (oral mucositis, cancer) with enhanced specificity and regenerative potential, potentially reducing antibiotic reliance and improving long-term treatment outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.